Abstract
Leadless pacemakers offer the opportunity to avoid transvenous hardware among patients with tricuspid valve prostheses. We present the first case of a helix-based fixation leadless pacemaker implanted through valve-in-valve tricuspid prostheses in a 43-year-old female with extensive prior cardiac history. At the time of presentation, epicardial pacing was no longer a viable option in the setting of pacemaker dependence. Placement of a helix-fixed, leadless right ventricular pacemaker was performed as a bridge to dual-chamber leadless pacing. This was safely and effectively performed and highlighted favorable procedural characteristics that included RV cavity dimensions and prosthesis type.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Knops RE, Reddy VY, Ip JE, et al. A dual-chamber leadless pacemaker. N Engl J Med. 2023;388:2360–70.
Reddy VY, Exner DV, Cantillon DJ, et al. Percutaneous implantation of an entirely intracardiac leadless pacemaker. N Engl J Med. 2015;373:1125–35.
Reynolds D, Duray GZ, Omar R, et al. A leadless intracardiac transcatheter pacing system. N Engl J Med. 2016;374:533–41.
Hale BW, Bradley DJ, Zampi JD, Whiteside W, Cunnane R. First-in-human combined transcatheter tricuspid valve implantation with leadless VDD pacemaker via left internal jugular approach. HeartRhythm case Rep. 2022;8:155–9.
Del Corral MP, Covas P, Tracy C, Mercader M, Solomon A. Percutaneous VDD leadless pacer implant post recent bioprosthetic tricuspid valve replacement for infective endocarditis. Pacing Clin Electrophysiol. 2021;44:747–50.
Theis C, Huber C, Kaesemann P, et al. Implantation of leadless pacing systems in patients early after tricuspid valve surgery: a feasible option. Pacing Clin Electrophysiol. 2020;43:1486–90.
Turdubaev A, Fink T, Eitz T, Imnadze G. Transfemoral leadless pacemaker implantation after transcatheter tricuspid valve in ring implantation. Clin Res Cardiol. 2024;113:187–9.
Ip JE. Advanced helix-fixation leadless cardiac pacemaker implantation techniques to improve success and reduce complications. J Cardiovasc Electrophysiol. 2023;34:1268–76.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
Research reported in this publication was supported by the National Heart, Lung, And Blood Institute of the National Institutes of Health under Award Number K23HL143156 (to BAS). The following relationships exist related to this presentation: BS reports research support from AHA/PCORI, Abbott, Cardiva, Sanofi, and AltaThera; and consulting to Sanofi, InCarda, Milestone, Pfizer, and AltaThera.
Disclaimer
The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Steinberg, B.A., Tandar, A. & Whitehead, K.J. Helix-fixed leadless pacemaker implantation through a valve-in-valve tricuspid prosthesis via the femoral approach. J Interv Card Electrophysiol (2024). https://doi.org/10.1007/s10840-024-01814-x
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10840-024-01814-x